|
| U.S. Brand
Names |
|
| Plasmanate®; Plasma-Plex®;
Plasmatein®; Protenate® |
|
|
| Generic
Available |
|
|
No |
|
|
| Pharmacological Index |
|
|
Blood Product Derivative |
|
|
| Use |
|
|
Plasma volume expansion and maintenance of cardiac output in the treatment of
certain types of shock or impending shock |
|
|
| Pregnancy Risk
Factor |
|
|
C |
|
|
| Usual Dosage |
|
|
I.V.: 250-1500 mL/day |
|
|
| Administration |
|
|
Albumin administration must be completed within 6 hours after entering the
container, provided that administration is begun within 4 hours of entering the
container; rapid infusion may cause vascular overload |
|
|
| Nursing
Implications |
|
|
5% albumin and 5% plasma protein fraction can usually be used
interchangeably |
|
|
| Dosage Forms |
|
|
Injection: 5% (50 mL, 250 mL, 500
mL) |
|
|
Copyright © 2007 Drugs Area
|
